Hang in there GALE longs, December lows are almost past. We float over $2 right away. Biotech is getting crushed from Giliad losing some market share for it's hep C drug to a smaller player. Ummm Gale is a smaller player so just wait till that turn of sentiment shines a light on GALE's pipeline. All the good news that hasn't moved GALE, will soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.